Ultrasis Plc Regulatory News (ULT)

3 May 2005 09:14

Ultrasis PLC03 May 2005 Ultrasis PLC New Appointment Announcement ULTRASIS APPOINTS NEW UK DIRECTOR OF SALESInteractive healthcare specialists, Ultrasis plc, have appointed a new UKDirector of Sales in order to harvest increasing market potential. Assuming hisnew position as of 1st of May, John Smith will develop the market for thecompany's range of computer based products, both amongst Primary Care Trustskeen to use effective drug-free alternatives in the treatment of depression, aswell as employers who in line with current legislation wish to take proactivesteps to reduce stress in the workplace. Graham Lewis, Chief Executive of Ultrasis commented; "Mental health includingstress-related illness is now widely acknowledged as the number one cause ofworkplace absenteeism, a fact underlined by the Health and Safety Executive'smove in November 2004 to issue new guidelines to employers on this issue.Combined, these factors mean that the market for our products is growingrapidly. John's appointment will give us increased capacity to actively ensureUltrasis take full advantage of this market opportunity." John, who was previously an Executive Director of a national charity, MentalHealth Matters, has extensive experience within the NHS, most recently asDirector of Innovation and Redesign for the 5 Boroughs Partnership NHS Trustproviding specialist mental health services to the people of Warrington, StHelens, Knowsley, Wigan and Halton. One of his key achievements during this timewas the introduction of Ultrasis Relief Series to the population of St Helens asa treatment for depression and anxiety and was very impressed with the results. "Having witnessed very favourable experiences from the customer perspective, Itruly believe in the Ultrasis product range and am delighted to have theopportunity to develop it on a national scale," John commented. "I feel there ishuge scope for these drug-free treatments for stress, anxiety and depressionwhich are not only proven and cost-effective to implement but are also wanted bythe people who experience the effects of mental ill-health." Graham added; "I see John's appointment as a very positive move for Ultrasis.His background in the field of mental health, network contacts and directexperience of our product's effectiveness will be great assets in developingUltrasis' continued growth. We believe our products are the best on the market,and now recommended by NICE for use in the NHS, we are very pleased that Johnhas joined forces with us." ENDS EnquiriesUltrasis PlcCharlie Martin, Executive Director0207 566 3900 This information is provided by RNS The company news service from the London Stock Exchange